首页> 美国卫生研究院文献>Pakistan Journal of Medical Sciences >Stevens Johnson Syndrome associated with Lamotrigine
【2h】

Stevens Johnson Syndrome associated with Lamotrigine

机译:史蒂文斯·约翰逊综合症与拉莫三嗪有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stevens-Johnsons Syndrome (SJS) is an immune-complex-mediated hypersensitivity reaction and has been linked as an adverse side effects to many drugs. Lamotrigine, an anticonvulsive medication and also a commonly used mood stabiliser, can be associated with this adverse reaction. Although this has not been reported very commonly , SJS has high mortality and morbidity and requires careful attention as the use of Lamotrigine is increasing in clinical practice. We present a case where the patient developed Stevens - Johnson Syndrome three weeks after being started on Lamotrigine. The case is discussed for its relevance to the use of Lamotrigine which is currently prescribed very commonly in psychiatric practices.
机译:史蒂文斯-约翰逊综合症(SJS)是一种免疫复合物介导的超敏反应,已被认为对许多药物具有不良副作用。拉莫三嗪,一种抗惊厥药,也是一种常用的情绪稳定剂,可能与这种不良反应有关。尽管尚未对此进行报道,但随着临床实践中拉莫三嗪的使用不断增加,SJS的死亡率和发病率较高,需要引起高度重视。我们介绍了一名患者在开始接受拉莫三嗪治疗三周后出现了史蒂文斯-约翰逊综合症。讨论了该病例与使用拉莫三嗪的相关性,拉莫三嗪目前在精神病学实践中很常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号